Sage Journals: Discover world-class research

Abstract

Modern pain therapy widely follows the WHO (World Health Organization) guidelines using a three-step ‘ladder’ for pain relief. This escalating step scheme includes the administration in the order nonopioids, mild opioids and strong opioids, and adjuvants at any step. Analgesics should be given ‘by the clock’ rather than ‘on demand’. However, the chronobiological parameters circadian pain rhythm, circadian efficacy of analgesics, and individual circadian need for analgesics are to be considered. The results of a multitude of studies in chronobiology are not consistent. Therefore, further studies with standardized protocols are needed that allow to assign more consistent rhythms to diseases, pain causes, and analgesic efficacy of opioids. In many cases, each patient perceives pain and its intensity individually during the time of day. By administration of analgesics over a constant or continuous dosage time fluctuations in pain perception and the outcomes of many studies in chronobiology are ignored that prove the influence of biological rhythms on the pharmacokinetic and pharmacodynamic aspects of analgesics. As different types of pain show different rhythms (highest pain intensities arising at different times of the day) analgesics should be dosed flexibly. It is also very important that drug therapy can be adjusted individually to the pain rhythm of the patient as well as to the type and cause of pain. In severe pain, therapy should be particularly careful. A flexible dosage depending on pain intensity and rapid dose adjustment are essentials of a modern pain therapy. Therefore, opioids that are flexible to use are better suited to treat the individual pain of the patient than rigid modified release oral or transdermal systems. J Oncol Pharm Practice (2010) 16: 81—87.

Keywords

pain therapy chronobiology circadian rhythm severe pain opioid analgesics

Get full access to this article

View all access options for this article.

References

Lemmer B. Chronopharmakologie. Symposium Chronobiologie, Wien 2005; Abstr. p. 8.

Hildebrandt G. , Moser M. , Lehofer M. Chronobiologie and chronomedizin. Stuttgart: Hippokrates Verlag, 1998 , pp. 92-93.

Auvil-Novak SE The chronobiology, chronopharmacology, and chromotherapeutics of pain. Ann Rev Nurs Res 1999; 17: 133-53.

Labrecque G. , Vanier MC Biological rhythms in pain and in the effects of opioid analgesics. Pharmacol Ther 1995; 68: 129-47.

Pöllmann L. Duality of pain demonstrated by the circadian variation in tooth sensitivity. In: Haus E , Kabat H. eds. Chronobiology 1982-1983. Basel: Karger, 1984, pp. 225-28.

Aya AG , Vialles N. , Mangin R. et al. Chronobiology of labour pain perception: an observational study . Br J Anaesth 2004; 93(3): 451-53.

Bellamy N. , Sothern RB , Campbell J. Aspects of diurnal rhythmicity in pain, stiffness, and fatigue in patients with fibromyalgia. J Rheumatol 2004; 31(2): 379-89.

Chassard D. , Bruguerolle B. Chronobiology and anesthesia. Anesthesiology 2004; 100: 413-27.

Bruera E. , Macmillan K. , Kuehn N. , Miller MJ Zirkadian distribution of extra doses of narcotic analgesics in patients with cancer pain: a preliminary report. Pain 1992 ; 49: 311-14.

10.

Nicholson B. , Ross E. , Sasaki J. , Weil A. Randomized trial comparing polymer-coated extended-release morphine sulphate to controlled release oxycodone HCl in moderate to severe non-malignant pain. Curr Med Res Opin 2006; 22: 1503-14.

11.

Morris RW , Lutsch EF Susceptibility to morphine-induced analgesia in mice. Nature 1967; 216: 494-95.

12.

Bernstein Rill , Crocket RS , Smith RP Diurnal variations in the analgesic effectiveness of morphine in mice. Pharmacy Brioche Behav 1977; 6: 621-26.

13.

Yoshida M. , Ohdo S. , Takane H. , Tomiyoshi Y. , Matsuo A. , Yukawa E. et al. Chronopharmacology of analgesic effect and its tolerance induced by morphine in mice. J Pharmacol Exp Ther 2003; 305(3): 1200-05.

14.

Wesche DL , Frederickson RC The role of the pituitary in the diurnal variation in tolerance to painful stimuli and brain enkephalin levels. Life Sci 1981; 29: 2199-205.

15.

Lemmer B. Chronopharmakologie; Tagesrhythmen and Arzneimittelwirkung. 3. Auflage. Stuttgart: Wissenschaftliche Verlagsgesellschaft mbH , 2004, pp. 70-77.

16.

Naber D. , Wirz-Justice A. , Kafka MS Zirkadian rhythm in rat brain opiate receptor. Neurosci Lett 1981; 21: 45-50.

17.

Petraglia F. , Facchinetti F. , Parrini D. , Micieli G. , De Luca S. , Genazzani AR Simultaneous circadian variation of plasma ACTH, ß-lipoprotein, ß-endorphin and cortisol. Horm Res 1983; 17: 147-52.

18.

Graves DA , Batenhorst RL , Bennett RL , Wettstein JG , Griffen WO , Wright BD et al. Morphine requirements using patient-controlled analgesia: influence of diurnal variation and morbid obesity. Clin Pharm 1983; 2: 49-53.

19.

Labrecque G. , Lepage-Savary D. , Poulin E. Time-dependent variations in morphine-induced analgesia. Annu Rev Chronopharmacol 1988; 5: 135-38.

20.

Auvil-Novak SE , Novak RD , Smolensky MH , Kavanagh JJ , Kwan JW , Wharton JT Twenty-four hour variation in self-administration of morphine sulfate and hydromorphone by post-surgical gynecologic cancer patients. Annu Rev Chronopharmacol 1988; 5: 343-46.

21.

Auvil-Novak SE , Novak RD , Smolensky MH , Morris MM , Kwan JW Temporal variation in the self-administration of morphine sulfate via patient-controlled analgesia in postoperative gynecologic cancer patients. Annu Rev Chronopharmacol 1990; 7: 253-56.

22.

Vanier MC , Labrecque G. , Lepage-Savary D. Temporal changes in hydro-morphine analgesia in cancer patients. In Smolensky MH et al. eds. Proceedings of the 5th international conference on biological rhythms and medications . Houston: Pergamon Press, 1992, Abstr. XIII-8.

23.

Pan PH , Lee S. , Harris L. Chronobiology of subarachnoid fentanyl for labour analgesia. Anesthesiol 2005; 103(3): 595-599.

24.

Wilder-Smith CH , Wilder-Smith OH Diurnal patterns of pain in cancer patients during treatment with long-acting opioid analgesics. In Smolensky MH et al. eds. Proceedings of the 5th international conference on biological rhythms and medications . Houston: Pergamon Press, 1992, Abstr. XIII-7.

25.

Wilder-Smith CH , Schimke JH , Bettiga A. Circadian pain responses with tramadol, a short-acting opioid and alpha-adrenergic agonist, and morphine in cancer pain. In Smolensky MH et al. eds. Proceedings of the 5th international conference on biological rhythms and medications. Houston: Pergamon Press, 1992.

26.

Peat S. , Sweet P. , Miah Y. , Barklamb M. , Larsen U. Assessment of analgesia in human chronic pain. Randomized double-blind crossover study of once daily repro-dose morphine versus MST continues. Eur J Clin Pharmacol 1999; 55: 577-81.

27.

Rauck RL , Bookbinder SA , Bunker TR , Alftine CD , Ghalie R. , Negro-Vilar A. et al. The ACTION study: a randomized, open-label, multicenter trial comparing once-a-day extended-release morphine sulfate capsules (AVINZA) to twice-a-day controlled-release oxycodone hydrochloride tablets (OxyContin) for the treatment of chronic, moderate to severe low back pain. J Opioid Manag 2006; 2(3): 155-66.

28.

Rauck RL , Bookbinder SA , Bunker TR , Alftine CD , Gershon S. , de Jong E. et al. A randomized open-label study of once-a-day AVINZA versus twice-a-day oxycontin for chronic low back pain: the extension phase of the ACTION trial . J Opioid Manag 2007; 3(1): 35-43.

29.

Bruera E. , Belzile M. , Neumann CM , Ford I. , Harsanyi Z. , Darke A. Twice-daily versus once-daily morphine sulphate controlled release suppositories for the treatment of cancer pain. Support Care Cancer 1999; 7: 280-283.

30.

Wagner T. , Heinze U. Retardiertes Hydromorphon in der Therapie tageszeitlich unterschiedlicher Schmerzintensitäten bei Tumorpatienten and multimorbiden Patienten. Poster, Der Deutsche Schmerztag, Frankfurt, 2007.

31.

Hanks GW , De Conno F. , Cherny N. , Hanna M. , Kalso E. , McQuay HJ et al. Morphine and alternative opioids in cancer pain: the EAPC recommendations . Brit J Cancer 2001; 84: 587-93.

32.

Radbruch L. , Nauck F. Morphin and andere Opioide in der Tumorschmerztherapie - Die Empfehlungen der EAPC. Schmerz 2002; 16: 186-93.

33.

Ahmedzai S. , Brooks D. Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. The TTS-Fentanyl Comparative Trial Group. J Pain Sympt Manage 1997; 13(5): 254-61.

34.

Pöllmann L. Study on the chronobiology of the teeth. Rev Stomatol Chir Maxillofac 1981; 82: 201-03.

35.

Wirz S. , Wittman M. , Schenk M. , Schroeck A. , Schaefer N. , Mueller M. et al. Gastrointestinal symptoms under opioid therapy: a prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl and transdermal buprenorphine. Eur J Pain 2008, October 30 [Epub ahead of print].

Review Article: Chronobiology: influence of circadian rhythms on the therapy of severe pain

Abstract

Keywords

Get full access to this article

References